
    
      Primary:

      To evaluate the effect of MBX-8025 on Alkaline Phosphatase (AP) levels

      Secondary:

      To evaluate the safety and tolerability of MBX-8025 in subjects with Primary Biliary
      Cirrhosis (PBC) To evaluate the effects of MBX-8025 on Primary Biliary Cirrhosis (PBC)
      response criteria To evaluate the effects of MBX-8025 on other markers of liver function,
      lipids, pruritus and Quality of Life (QoL)

      Exploratory:

      To evaluate the effect of MBX-8025 on liver imaging and other biochemical markers that may be
      relevant to the pathophysiology of PBC or the mechanism of action of the drug
    
  